Recent Finacing
Recent Raise
BioVex is a biotech developing oncolytic herpes simplex virus therapies engineered to express GM-CSF, conducting clinical trials for melanoma and head/neck cancers and developing a genital herpes vaccine.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
